{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=pravastatin+sodium&page=3", "query": { "intervention": "pravastatin sodium", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 75, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=pravastatin+sodium&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=pravastatin+sodium&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T12:42:29.964Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00571194", "title": "Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arkansas Children's Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "12 Months to 18 Years" }, "enrollment_count": 7, "start_date": "2007-09", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2017-03-15", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00571194" }, { "nct_id": "NCT05852769", "title": "A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "BMS-986196", "type": "DRUG" }, { "name": "Caffeine", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Flurbiprofen", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Digoxin", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 18, "start_date": "2023-05-31", "completion_date": "2023-08-24", "has_results": false, "last_update_posted_date": "2023-09-26", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Millcreek, Utah", "locations": [ { "city": "Millcreek", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05852769" }, { "nct_id": "NCT00039663", "title": "Endothelial Dysfunction as a Risk Factor in HIV Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Pravastatin", "type": "DRUG" }, { "name": "Gemfibrozil", "type": "DRUG" }, { "name": "Rosiglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 75, "start_date": "2002-05", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00039663" }, { "nct_id": "NCT01441908", "title": "Longitudinal Study of Multi-Analyte Profile for Dyslipidemia", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MaiHealth Inc", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "30 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2011-06", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2012-04-16", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Raleigh, North Carolina", "locations": [ { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01441908" }, { "nct_id": "NCT01845428", "title": "Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nephrotic Syndrome", "Hyperlipidemia" ], "interventions": [ { "name": "Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 7, "start_date": "2012-05", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01845428" }, { "nct_id": "NCT02621957", "title": "Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "GDC-0810", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 15, "start_date": "2015-12", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Daytona Beach, Florida", "locations": [ { "city": "Daytona Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02621957" }, { "nct_id": "NCT00330980", "title": "Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dyslipidemias" ], "interventions": [ { "name": "40 mg Pravastatin (Pravachol)", "type": "DRUG" }, { "name": "20 mg Simvastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": null, "sex": "ALL", "summary": "20 Years and older" }, "enrollment_count": 1000, "start_date": "2000-04", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2014-03-20", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00330980" }, { "nct_id": "NCT05524246", "title": "Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hematopoietic Stem Cell Transplant (HSCT)", "Endothelial Injury" ], "interventions": [ { "name": "Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "2 Years to 25 Years" }, "enrollment_count": 25, "start_date": "2023-01-27", "completion_date": "2025-03-05", "has_results": false, "last_update_posted_date": "2025-04-18", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05524246" }, { "nct_id": "NCT01497483", "title": "Drug-Drug Interaction Study With Pravastatin and Cyclosporine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Pravastatin alone", "type": "DRUG" }, { "name": "Pravastatin and Cyclosporine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 21, "start_date": "2011-12", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2015-01-16", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01497483" }, { "nct_id": "NCT00006412", "title": "Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections", "Lipodystrophy" ], "interventions": [ { "name": "Pravastatin sodium", "type": "DRUG" }, { "name": "Fenofibrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 630, "start_date": null, "completion_date": "2003-05", "has_results": false, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-10-06T12:42:29.964Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Los Angeles, California • Menlo Park, California + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Menlo Park", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006412" } ] }